Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nomenclature for leukotrienes

B Samuelsson, S Hammarström

    Prostaglandins
    |May 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    A new nomenclature system for leukotrienes has been developed, classifying them by their cysteine substituent and double bond count. This system aids in organizing and understanding these important signaling molecules.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Slow-reacting substances and leukotrienes.

    Immunology today·2014
    Same author

    Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer.

    Journal of internal medicine·2010
    Same author

    Attenuation of the virulence of Porphyromonas gingivalis by using a specific synthetic Kgp protease inhibitor.

    Infection and immunity·2002
    Same author

    Expression of microsomal glutathione S-transferase type 3 mRNA in the rat nervous system.

    Neuroscience·2002
    Same author

    Resistance profiles of cyclic and linear inhibitors of HIV-1 protease.

    Antiviral chemistry & chemotherapy·2002
    Same author

    Solid-phase synthesis of libraries generated from a 4-phenyl-2-carboxy-piperazine scaffold.

    Journal of combinatorial chemistry·2001

    Area of Science:

    • Biochemistry
    • Organic Chemistry
    • Pharmacology

    Background:

    • Leukotrienes are key lipid mediators involved in inflammation and allergic responses.
    • Existing nomenclature systems for leukotrienes require expansion to encompass newly discovered compounds.
    • Understanding leukotriene structure is crucial for developing targeted therapies.

    Purpose of the Study:

    • To extend the existing nomenclature for leukotrienes.
    • To classify leukotrienes based on their chemical structure, specifically the cysteine substituent and the number of double bonds.
    • To provide a unified framework for novel and previously described leukotriene compounds.

    Main Methods:

    • Systematic analysis of the chemical structures of known and novel leukotrienes.

    Related Experiment Videos

  • Categorization based on the type of cysteine-containing side chain.
  • Quantification of the total number of double bonds within the leukotriene backbone.

    • Main Results:

    • A comprehensive nomenclature system was established, incorporating structural features.
    • New classes of leukotrienes were identified and systematically named.
    • The extended nomenclature successfully accommodates a wider range of leukotriene structures.

    Conclusions:

    • The proposed nomenclature provides a robust and systematic method for classifying leukotrienes.
    • This classification facilitates clearer communication and organization of research in lipid mediator science.
    • The system aids in the identification and study of novel leukotriene analogs for therapeutic development.